NEIMETH - Neimeth International Pharma
Neimeth International Pharmaceuticals Plc is the resultant company from the management-buy-out of the 60% equity holding of Pfizer Inc. in Pfizer Products Plc. This management-buy-out took place in May 1997 when Pfizer Inc., in pursuit of its global repositioning strategy, divested 60% equity in Pfizer Products Plc. in favour of the existing management. Before the brand name Neimeth International Pharmaceuticals Plc, the company had operated in Nigeria for 40 years, manufacturing, marketing, and distributing Pfizer brands of pharmaceutical and veterinary products in tablets, capsules, ointment/cream, powder, injectables, and oral liquid forms.
|Last Trading Results|
|Day’s Low Price|
|Day’s High Price|
|Number of Deals||6|
|Growth & Valuation|
|Earnings Per Share||0.02|
|Dividend Per Share|
NEIMETH Stock Market Performance
The current share price of Neimeth International Pharma (NEIMETH) is NGN 1.75. NEIMETH closed its last trading day (Friday, July 30, 2021) at 1.75 NGN per share on the Nigerian Stock Exchange (NGX). Neimeth International Pharma began the year with a share price of 2.23 NGN but has since lost 21.5% off that price valuation, ranking it 146th on the NGX in terms of year-to-date performance.
Neimeth International Pharma is the 77th most traded stock on the Nigerian Stock Exchange over the past three months (Apr 27 - Jul 30, 2021). NEIMETH has traded a total volume of 13.7 million shares—in 611 deals—valued at NGN 24.4 million over the period, with an average of 217,875 traded shares per session. A volume high of 921,468 was achieved on July 27th for the same period. The table below details the last 10 trading days of activity of Neimeth International Pharma on the Nigerian Stock Exchange.
Profile of Neimeth International Pharmaceuticals Plc
Neimeth International Pharmaceuticals Plc operates in the Health Care sector, specifically, the Pharmaceuticals & Biotechnology industry.
|Factsheet of Neimeth International Pharmaceuticals Plc|
Pharmaceuticals & Biotechnology
Plot 16, Akanni Doherty Layout, Oregun Industrial Estate, Oregun, Lagos, Nigeria
NEIMETH Industrial Market Competitors
Neimeth International Pharmaceuticals Plc, issuers of the NEIMETH stock on the Nigerian Stock Exchange, have seven market competitors who are also engaged in the Health Care sector and/or Pharmaceuticals & Biotechnology industry. The table below presents an overview of their market standing.
|MAYBAKER||May & Baker Nigeria||8.11B||4.70||+33.9%|
|GLAXOSMITH||Glaxo Smithkline Consumer||7.41B||6.20||-10.1%|